Pharmacy Center

Network e-Rx triage, 3-way medication sync, NDC draft adjudication, and the director approval queue.

Network e-Rx triage

OrderPracticePatientICD-10Medication
erx-1solo-practice-1-sgvjane-doeN39.0nitrofurantoin 100 mg twice daily
erx-2solo-practice-2-arcadiamichael-chenN41.0ciprofloxacin
erx-3solo-practice-1-sgvjane-doeE11.9metformin 500 mg

Pharmacist NDC billing / adjudication

AI formulary approval queue

Approval controls are limited to MEDICAL_PHARMACIST_DIRECTOR.

  • N39.0 · Uncomplicated cystitis · 1 order(s) · pending-director

    Trimethoprim-sulfamethoxazole DS twice daily for 3 days when local resistance, allergy, and pregnancy status allow. Nitrofurantoin is a separate 5-day alternative.

    Evidence rule for N39.0 stages a 3-day cystitis course for MEDICAL_PHARMACIST_DIRECTOR approval before PHARMACY_CENTER_MASTER.

  • N41.0 · Acute prostatitis · 1 order(s) · pending-director

    28-day outpatient course for acute prostatitis (fluoroquinolone or trimethoprim-sulfamethoxazole) only when the patient is stable for outpatient care. Sepsis, retention, or unstable vitals are outside this template.

    Evidence rule for N41.0 stages a 28-day prostatitis course for MEDICAL_PHARMACIST_DIRECTOR approval before PHARMACY_CENTER_MASTER.

  • E11.9 · No evidence rule on file · 1 order(s) · pending-director

    Director must supply the regimen. This cluster is not evidence-backed.

    E11.9 has 1 network order(s) and no evidence rule. Staged for director review only.